Nomination Summary for Methdilazine (N80305)

Nominated Substances: Methdilazine

Nomination Date: 11/00/1979

Nominator: FDA

Rationale: potential for wide exposure as possible substitute for the antihistamine methapyrilene which had been shown to induce hepatic tumors in rats

NTP Principles: Pre 1993 - 2, 6


Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.


CASRN: 1982-37-2

Agent Name: Methdilazine